Besides, LIPG has the ability to hydrolyze fatty acids from both PCs and LPCs, and LIPG has a significant association with features of MetS, it may potentially serve as a pro-atherogenic factor in individuals with MetS (Fig. 4) [42]. Here, LIPG is linked to metabolic syndrome.